Resolution of oral ulcerations after decreasing the dosage of tacrolimus in a liver transplantation recipient.
Oral ulcers have may possible causes, including immunosuppression and drug therapy. Severe cases of oral ulceration merit special consideration because the ulcers may become large enough to alter the quality of life of the patient. The present case involves a male patient who in 1994 received an orthotopic liver transplantation because of alcoholic cirrhosis. The initial immunosuppressive regimen was induced with tacrolimus (4 mg/d) and prednisone (20 mg/d). Ten months after orthotopic liver transplantation, the patient complained of multiple recurrent oral ulcers, dysphagia, and severe oral pain, which did not respond to any of the treatments over a 3-year period. Approximately 3(1/4) years after these unresponsive ulcers appeared, the reduction of the oral dosage of tacrolimus resulted in the total remission of the ulcers. A retrospective analysis demonstrated that appearance of the ulcers coincided with a dose of 9 mg/d of tacrolimus (whole blood levels of 12 ng/mL); the ulcers did not disappear until the dose was reduced to 4 mg/d (whole blood level of 6.6 ng/mL).
Hernández
G
G
Department of Medicine and Buccofacial Surgery, School of Dentistry, Complutense University, Madrid, Spain. ghervall@eucmax.sim.ucm.es
Jiménez
C
C
Arriba
L
L
Moreno
E
E
Lucas
M
M
D000284:Administration, Oral; D003680:Deglutition Disorders / Q000139:chemically induced / Q000517:prevention & control; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D008104:Liver Cirrhosis, Alcoholic / Q000601:surgery; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D019226:Oral Ulcer / Q000139:chemically induced / Q000517:prevention & control*; D012008:Recurrence; D012189:Retrospective Studies; D016559:Tacrolimus / Q000008:administration & dosage* / Q000009:adverse effects / Q000097:blood; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D016559:Tacrolimus